Yossef Daar - 10 Jul 2026 Form 4 Insider Report for CYABRA, INC. (CYAB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Jul 2026, 17:10:22 UTC
Prior SEC filing
18 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Yael Sandler, Attorney-in-Fact

Key filing fact

Yossef Daar filed Form 4 for CYABRA, INC. (CYAB) on 13 Jul 2026.

Key facts

  • This page summarizes Yossef Daar's Form 4 filing for CYABRA, INC. (CYAB).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 13 Jul 2026, 17:10.

Change

  • Previous filing in this sequence was filed on 18 May 2026.
  • Current net transaction value: +$50,968.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002045600 Primary reporting owner

Daar Yossef

Relationship
Chief Product Officer, Director
Address
C/O CYABRA, INC., 13 GERSHON SHATZ, TEL AVIV, ISRAEL
Signature
/s/ Yael Sandler, Attorney-in-Fact
Signature date
13 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYAB transaction

Common Stock

Award

Transaction value
Shares
+53,650
Change %
+6.4%
Price
$0.4350*
Shares after
894,199
Date
10 Jul 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYAB transaction Derivative

Common Stock Warrants (right to buy)

Purchase

Transaction value
$24,142
Shares
+53,650
Change %
Price
$0.4500
Shares after
53,650
Date
10 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
53,650
Exercise price
$0.4500
Footnotes
F2, F3, F4
CYAB transaction Derivative

Common Stock Warrants (right to buy)

Purchase

Transaction value
$26,825
Shares
+53,650
Change %
+100%
Price
$0.5000
Shares after
107,300
Date
10 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
53,650
Exercise price
$0.5000
Footnotes
F5, F6, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share.

Footnote F2

The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement.

Footnote F3

The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval.

Footnote F4

The Series B Warrants expire twelve (12) months following the initial exercise date.

Footnote F5

The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement.

Footnote F6

The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval.

Footnote F7

The Series A Warrants expire five (5) years following the initial exercise date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .